久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • US FDA approves Siliq to treat plaque psoriasis pharmaceutical-technology
    February 17, 2017
    FDA Center for Drug Evaluation and Research Office of Drug Evaluation III director Julie Beitz said: "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today’s approval provides patients with anothe
  • Siliq Approved By the FDA for Adult Patients with Moderate-to-Severe Plaque Psoriasis americanpharmaceuticalreview
    February 17, 2017
    AstraZeneca’s partner Valeant Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Siliq (brodalumab) injection for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for syst
PharmaSources Customer Service